ID   HDAC5_HUMAN             Reviewed;        1122 AA.
AC   Q9UQL6; C9JFV9; O60340; O60528; Q96DY4;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   04-FEB-2015, entry version 159.
DE   RecName: Full=Histone deacetylase 5;
DE            Short=HD5;
DE            EC=3.5.1.98;
DE   AltName: Full=Antigen NY-CO-9;
GN   Name=HDAC5; Synonyms=KIAA0600;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10220385; DOI=10.1073/pnas.96.9.4868;
RA   Grozinger C.M., Hassig C.A., Schreiber S.L.;
RT   "Three proteins define a class of human histone deacetylases related
RT   to yeast Hda1p.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:4868-4873(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-176 (ISOFORM 3).
RC   TISSUE=Neuroblastoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 189-1122 (ISOFORM 1).
RC   TISSUE=Colon carcinoma;
RX   PubMed=9610721;
RX   DOI=10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.0.CO;2-P;
RA   Scanlan M.J., Chen Y.-T., Williamson B., Gure A.O., Stockert E.,
RA   Gordan J.D., Tuereci O., Sahin U., Pfreundschuh M., Old L.J.;
RT   "Characterization of human colon cancer antigens recognized by
RT   autologous antibodies.";
RL   Int. J. Cancer 76:652-658(1998).
RN   [8]
RP   GENE ORGANIZATION.
RX   PubMed=11018260; DOI=10.1016/S0167-4781(00)00191-3;
RA   Mahlknecht U., Schnittger S., Ottmann O.G., Schoch C., Mosebach M.,
RA   Hiddemann W., Hoelzer D.;
RT   "Chromosomal organization and localization of the human histone
RT   deacetylase 5 gene (HDAC5).";
RL   Biochim. Biophys. Acta 1493:342-348(2000).
RN   [9]
RP   INTERACTION WITH BCOR.
RX   PubMed=10898795;
RA   Huynh K.D., Fischle W., Verdin E., Bardwell V.J.;
RT   "BCoR, a novel corepressor involved in BCL-6 repression.";
RL   Genes Dev. 14:1810-1823(2000).
RN   [10]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION, AND MUTAGENESIS OF SER-259;
RP   SER-279; SER-498; SER-661 AND SER-713.
RX   PubMed=11081517; DOI=10.1038/35040593;
RA   McKinsey T.A., Zhang C.-L., Lu J., Olson E.N.;
RT   "Signal-dependent nuclear export of a histone deacetylase regulates
RT   muscle differentiation.";
RL   Nature 408:106-111(2000).
RN   [11]
RP   INTERACTION WITH 14-3-3, AND PHOSPHORYLATION AT SER-259 AND SER-498.
RX   PubMed=11114197; DOI=10.1073/pnas.260501497;
RA   McKinsey T.A., Zhang C.-L., Olson E.N.;
RT   "Activation of the myocyte enhancer factor-2 transcription factor by
RT   calcium/calmodulin-dependent protein kinase-stimulated binding of 14-
RT   3-3 to histone deacetylase 5.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:14400-14405(2000).
RN   [12]
RP   NUCLEAR EXPORT SIGNAL, AND MUTAGENESIS OF VAL-1086 AND LEU-1092.
RX   PubMed=11509672; DOI=10.1128/MCB.21.18.6312-6321.2001;
RA   McKinsey T.A., Zhang C.-L., Olson E.N.;
RT   "Identification of a signal-responsive nuclear export sequence in
RT   class II histone deacetylases.";
RL   Mol. Cell. Biol. 21:6312-6321(2001).
RN   [13]
RP   UBIQUITINATION.
RX   PubMed=12354939; DOI=10.1073/pnas.172511699;
RA   Hook S.S., Orian A., Cowley S.M., Eisenman R.N.;
RT   "Histone deacetylase 6 binds polyubiquitin through its zinc finger
RT   (PAZ domain) and copurifies with deubiquitinating enzymes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:13425-13430(2002).
RN   [14]
RP   INTERACTION WITH BCL6.
RX   PubMed=12504096; DOI=10.1016/S0006-291X(02)02873-5;
RA   Mascle X., Albagli O., Lemercier C.;
RT   "Point mutations in BCL6 DNA-binding domain reveal distinct roles for
RT   the six zinc fingers.";
RL   Biochem. Biophys. Res. Commun. 300:391-396(2003).
RN   [15]
RP   INTERACTION WITH KDM5B.
RX   PubMed=17373667; DOI=10.1002/ijc.22673;
RA   Barrett A., Santangelo S., Tan K., Catchpole S., Roberts K.,
RA   Spencer-Dene B., Hall D., Scibetta A., Burchell J., Verdin E.,
RA   Freemont P., Taylor-Papadimitriou J.;
RT   "Breast cancer associated transcriptional repressor PLU-1/JARID1B
RT   interacts directly with histone deacetylases.";
RL   Int. J. Cancer 121:265-275(2007).
RN   [16]
RP   INTERACTION WITH DDIT3.
RX   PubMed=17872950; DOI=10.1074/jbc.M703735200;
RA   Ohoka N., Hattori T., Kitagawa M., Onozaki K., Hayashi H.;
RT   "Critical and functional regulation of CHOP (C/EBP homologous protein)
RT   through the N-terminal portion.";
RL   J. Biol. Chem. 282:35687-35694(2007).
RN   [17]
RP   PHOSPHORYLATION AT SER-259 AND SER-498, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF SER-259 AND SER-498.
RX   PubMed=18184930; DOI=10.2337/db07-0843;
RA   McGee S.L., van Denderen B.J., Howlett K.F., Mollica J.,
RA   Schertzer J.D., Kemp B.E., Hargreaves M.;
RT   "AMP-activated protein kinase regulates GLUT4 transcription by
RT   phosphorylating histone deacetylase 5.";
RL   Diabetes 57:860-867(2008).
RN   [18]
RP   PHOSPHORYLATION AT SER-259 AND SER-498.
RX   PubMed=18332134; DOI=10.1074/jbc.M800264200;
RA   Ha C.H., Wang W., Jhun B.S., Wong C., Hausser A., Pfizenmaier K.,
RA   McKinsey T.A., Olson E.N., Jin Z.G.;
RT   "Protein kinase D-dependent phosphorylation and nuclear export of
RT   histone deacetylase 5 mediates vascular endothelial growth factor-
RT   induced gene expression and angiogenesis.";
RL   J. Biol. Chem. 283:14590-14599(2008).
RN   [19]
RP   INTERACTION WITH BAHD1.
RX   PubMed=19666599; DOI=10.1073/pnas.0901259106;
RA   Bierne H., Tham T.N., Batsche E., Dumay A., Leguillou M.,
RA   Kerneis-Golsteyn S., Regnault B., Seeler J.S., Muchardt C.,
RA   Feunteun J., Cossart P.;
RT   "Human BAHD1 promotes heterochromatic gene silencing.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:13826-13831(2009).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-533, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [21]
RP   PHOSPHORYLATION AT THR-292, AND MUTAGENESIS OF SER-259; SER-291 AND
RP   THR-292.
RX   PubMed=20188095; DOI=10.1016/j.febslet.2010.02.057;
RA   Harrison B.C., Huynh K., Lundgaard G.L., Helmke S.M., Perryman M.B.,
RA   McKinsey T.A.;
RT   "Protein kinase C-related kinase targets nuclear localization signals
RT   in a subset of class IIa histone deacetylases.";
RL   FEBS Lett. 584:1103-1110(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   FUNCTION, AND INTERACTION WITH EP300.
RX   PubMed=24413532; DOI=10.1158/0008-5472.CAN-13-2020;
RA   Kang H.J., Lee M.H., Kang H.L., Kim S.H., Ahn J.R., Na H., Na T.Y.,
RA   Kim Y.N., Seong J.K., Lee M.O.;
RT   "Differential regulation of estrogen receptor alpha expression in
RT   breast cancer cells by metastasis-associated protein 1.";
RL   Cancer Res. 74:1484-1494(2014).
CC   -!- FUNCTION: Responsible for the deacetylation of lysine residues on
CC       the N-terminal part of the core histones (H2A, H2B, H3 and H4).
CC       Histone deacetylation gives a tag for epigenetic repression and
CC       plays an important role in transcriptional regulation, cell cycle
CC       progression and developmental events. Histone deacetylases act via
CC       the formation of large multiprotein complexes. Involved in muscle
CC       maturation by repressing transcription of myocyte enhancer MEF2C.
CC       During muscle differentiation, it shuttles into the cytoplasm,
CC       allowing the expression of myocyte enhancer factors. Involved in
CC       the MTA1-mediated epigenetic regulation of ESR1 expression in
CC       breast cancer. {ECO:0000269|PubMed:24413532}.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of an N(6)-acetyl-lysine residue of
CC       a histone to yield a deacetylated histone.
CC   -!- SUBUNIT: Interacts with AHRR, BAHD1, BCOR, HDAC7, HDAC9, CTBP1,
CC       MEF2C, NCOR2, NRIP1, PHB2 and a 14-3-3 chaperone protein.
CC       Interacts with BCL6, DDIT3/CHOP, GRK5, KDM5B and MYOCD. Interacts
CC       with EP300 in the presence of TFAP2C.
CC       {ECO:0000269|PubMed:10898795, ECO:0000269|PubMed:11114197,
CC       ECO:0000269|PubMed:12504096, ECO:0000269|PubMed:17373667,
CC       ECO:0000269|PubMed:17872950, ECO:0000269|PubMed:19666599,
CC       ECO:0000269|PubMed:24413532}.
CC   -!- INTERACTION:
CC       Q9HCU9:BRMS1; NbExp=2; IntAct=EBI-715576, EBI-714781;
CC       P08393:ICP0 (xeno); NbExp=3; IntAct=EBI-715576, EBI-6148881;
CC       Q13761:RUNX3; NbExp=5; IntAct=EBI-715576, EBI-925990;
CC       P31947:SFN; NbExp=3; IntAct=EBI-715576, EBI-476295;
CC       P63104:YWHAZ; NbExp=2; IntAct=EBI-715576, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Shuttles between
CC       the nucleus and the cytoplasm. In muscle cells, it shuttles into
CC       the cytoplasm during myocyte differentiation. The export to
CC       cytoplasm depends on the interaction with a 14-3-3 chaperone
CC       protein and is due to its phosphorylation at Ser-259 and Ser-498
CC       by AMPK, CaMK1 and SIK1.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UQL6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UQL6-2; Sequence=VSP_002081;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9UQL6-3; Sequence=VSP_039180;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: The nuclear export sequence mediates the shuttling between
CC       the nucleus and the cytoplasm. {ECO:0000250}.
CC   -!- PTM: Phosphorylated by AMPK, CaMK1, SIK1 and PRKD1 at Ser-259 and
CC       Ser-498. The phosphorylation is required for the export to the
CC       cytoplasm and inhibition. Phosphorylated by the PKC kinases PKN1
CC       and PKN2, impairing nuclear import. Phosphorylated by GRK5,
CC       leading to nuclear export of HDAC5 and allowing MEF2-mediated
CC       transcription (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. Polyubiquitination however does not lead to
CC       its degradation. {ECO:0000269|PubMed:12354939}.
CC   -!- SIMILARITY: Belongs to the histone deacetylase family. HD type 2
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC18040.1; Type=Frameshift; Positions=1085; Evidence={ECO:0000305};
CC       Sequence=BAA25526.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF132608; AAD29047.1; -; mRNA.
DR   EMBL; AB011172; BAA25526.2; ALT_INIT; mRNA.
DR   EMBL; AC023855; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC013140; AAH13140.1; ALT_TERM; mRNA.
DR   EMBL; BC051824; AAH51824.1; -; mRNA.
DR   EMBL; BX458255; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AF039691; AAC18040.1; ALT_FRAME; mRNA.
DR   EMBL; BK000028; DAA00017.1; -; Genomic_DNA.
DR   CCDS; CCDS32663.1; -. [Q9UQL6-3]
DR   CCDS; CCDS45696.1; -. [Q9UQL6-1]
DR   RefSeq; NP_001015053.1; NM_001015053.1. [Q9UQL6-3]
DR   RefSeq; NP_005465.2; NM_005474.4. [Q9UQL6-1]
DR   RefSeq; XP_005256961.1; XM_005256904.2. [Q9UQL6-3]
DR   RefSeq; XP_005256963.1; XM_005256906.2. [Q9UQL6-1]
DR   UniGene; Hs.438782; -.
DR   ProteinModelPortal; Q9UQL6; -.
DR   SMR; Q9UQL6; 96-133, 681-1061.
DR   BioGrid; 115331; 339.
DR   DIP; DIP-38260N; -.
DR   IntAct; Q9UQL6; 28.
DR   MINT; MINT-1407477; -.
DR   STRING; 9606.ENSP00000225983; -.
DR   BindingDB; Q9UQL6; -.
DR   ChEMBL; CHEMBL3038483; -.
DR   GuidetoPHARMACOLOGY; 2660; -.
DR   PhosphoSite; Q9UQL6; -.
DR   DMDM; 296434519; -.
DR   MaxQB; Q9UQL6; -.
DR   PaxDb; Q9UQL6; -.
DR   PRIDE; Q9UQL6; -.
DR   Ensembl; ENST00000225983; ENSP00000225983; ENSG00000108840. [Q9UQL6-3]
DR   Ensembl; ENST00000336057; ENSP00000337290; ENSG00000108840. [Q9UQL6-2]
DR   Ensembl; ENST00000586802; ENSP00000468004; ENSG00000108840. [Q9UQL6-1]
DR   GeneID; 10014; -.
DR   KEGG; hsa:10014; -.
DR   UCSC; uc002ifd.1; human. [Q9UQL6-1]
DR   UCSC; uc002iff.1; human. [Q9UQL6-3]
DR   UCSC; uc010czp.1; human. [Q9UQL6-2]
DR   CTD; 10014; -.
DR   GeneCards; GC17M042159; -.
DR   H-InvDB; HIX0013862; -.
DR   HGNC; HGNC:14068; HDAC5.
DR   HPA; CAB019400; -.
DR   HPA; HPA030991; -.
DR   MIM; 605315; gene.
DR   neXtProt; NX_Q9UQL6; -.
DR   PharmGKB; PA29230; -.
DR   eggNOG; COG0123; -.
DR   GeneTree; ENSGT00530000062809; -.
DR   HOGENOM; HOG000232065; -.
DR   HOVERGEN; HBG057100; -.
DR   InParanoid; Q9UQL6; -.
DR   KO; K11406; -.
DR   OMA; LGPYDSR; -.
DR   OrthoDB; EOG7RFTH5; -.
DR   PhylomeDB; Q9UQL6; -.
DR   TreeFam; TF106174; -.
DR   Reactome; REACT_118780; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; REACT_160243; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; REACT_160254; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   ChiTaRS; HDAC5; human.
DR   GeneWiki; Histone_deacetylase_5; -.
DR   GenomeRNAi; 10014; -.
DR   NextBio; 37831; -.
DR   PRO; PR:Q9UQL6; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; Q9UQL6; -.
DR   CleanEx; HS_HDAC5; -.
DR   ExpressionAtlas; Q9UQL6; baseline and differential.
DR   Genevestigator; Q9UQL6; -.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0000118; C:histone deacetylase complex; TAS:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0001047; F:core promoter binding; IDA:UniProtKB.
DR   GO; GO:0004407; F:histone deacetylase activity; IDA:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC.
DR   GO; GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC.
DR   GO; GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC.
DR   GO; GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC.
DR   GO; GO:0005080; F:protein kinase C binding; IPI:UniProtKB.
DR   GO; GO:0070491; F:repressing transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0003714; F:transcription corepressor activity; IEA:Ensembl.
DR   GO; GO:0008134; F:transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0042113; P:B cell activation; TAS:UniProtKB.
DR   GO; GO:0030183; P:B cell differentiation; TAS:UniProtKB.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; NAS:BHF-UCL.
DR   GO; GO:0016568; P:chromatin modification; TAS:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; TAS:UniProtKB.
DR   GO; GO:0006338; P:chromatin remodeling; TAS:ProtInc.
DR   GO; GO:0006342; P:chromatin silencing; TAS:ProtInc.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0016575; P:histone deacetylation; IDA:BHF-UCL.
DR   GO; GO:0006954; P:inflammatory response; TAS:UniProtKB.
DR   GO; GO:0033555; P:multicellular organismal response to stress; IEA:Ensembl.
DR   GO; GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; IMP:BHF-UCL.
DR   GO; GO:0010832; P:negative regulation of myotube differentiation; IMP:BHF-UCL.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0002076; P:osteoblast development; IEA:Ensembl.
DR   GO; GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0040029; P:regulation of gene expression, epigenetic; IMP:UniProtKB.
DR   GO; GO:0010830; P:regulation of myotube differentiation; ISS:UniProtKB.
DR   GO; GO:0043393; P:regulation of protein binding; IMP:BHF-UCL.
DR   GO; GO:0048742; P:regulation of skeletal muscle fiber development; IEA:Ensembl.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.800.20; -; 1.
DR   InterPro; IPR000286; His_deacetylse.
DR   InterPro; IPR023801; His_deacetylse_dom.
DR   InterPro; IPR024643; Hist_deacetylase_Gln_rich_N.
DR   InterPro; IPR017320; Histone_deAcase_II_euk.
DR   PANTHER; PTHR10625; PTHR10625; 1.
DR   Pfam; PF12203; HDAC4_Gln; 1.
DR   Pfam; PF00850; Hist_deacetyl; 1.
DR   PIRSF; PIRSF037911; HDAC_II_euk; 1.
DR   PRINTS; PR01270; HDASUPER.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromatin regulator;
KW   Complete proteome; Cytoplasm; Hydrolase; Metal-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repressor;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc.
FT   CHAIN         1   1122       Histone deacetylase 5.
FT                                /FTId=PRO_0000114701.
FT   REGION      684   1028       Histone deacetylase.
FT   MOTIF      1081   1122       Nuclear export signal.
FT   COMPBIAS     47     52       Poly-Gly.
FT   COMPBIAS     85     92       Poly-Gln.
FT   COMPBIAS    596    599       Poly-Glu.
FT   COMPBIAS   1099   1104       Poly-Ala.
FT   ACT_SITE    833    833       {ECO:0000250}.
FT   METAL       696    696       Zinc. {ECO:0000250}.
FT   METAL       698    698       Zinc. {ECO:0000250}.
FT   METAL       704    704       Zinc. {ECO:0000250}.
FT   METAL       781    781       Zinc. {ECO:0000250}.
FT   MOD_RES     259    259       Phosphoserine; by AMPK, CaMK1, SIK1 and
FT                                PKD/PRKD1. {ECO:0000269|PubMed:11114197,
FT                                ECO:0000269|PubMed:18184930,
FT                                ECO:0000269|PubMed:18332134}.
FT   MOD_RES     292    292       Phosphothreonine; by PKC.
FT                                {ECO:0000269|PubMed:20188095}.
FT   MOD_RES     498    498       Phosphoserine; by AMPK, CaMK1, SIK1 and
FT                                PKD/PRKD1. {ECO:0000269|PubMed:11114197,
FT                                ECO:0000269|PubMed:18184930,
FT                                ECO:0000269|PubMed:18332134}.
FT   MOD_RES     533    533       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:19608861}.
FT   MOD_RES     661    661       Phosphoserine.
FT                                {ECO:0000269|PubMed:11081517}.
FT   VAR_SEQ       7      7       S -> SA (in isoform 3).
FT                                {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_039180.
FT   VAR_SEQ     684    768       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9628581}.
FT                                /FTId=VSP_002081.
FT   VARIANT     137    137       R -> Q (in dbSNP:rs438096).
FT                                /FTId=VAR_055903.
FT   VARIANT     565    565       G -> A (in dbSNP:rs33916560).
FT                                /FTId=VAR_055904.
FT   MUTAGEN     259    259       S->A: Reduces AMPK- and caMK-dependent
FT                                phosphorylation and the subsequent
FT                                nuclear export. Abolishes nuclear export;
FT                                when associated with A-498. Does not
FT                                affect phosphorylation by PKN1 and PKN2.
FT                                {ECO:0000269|PubMed:11081517,
FT                                ECO:0000269|PubMed:18184930,
FT                                ECO:0000269|PubMed:20188095}.
FT   MUTAGEN     279    279       S->A: No effect.
FT                                {ECO:0000269|PubMed:11081517}.
FT   MUTAGEN     291    291       S->A: Does not affect phosphorylation by
FT                                PKC. {ECO:0000269|PubMed:20188095}.
FT   MUTAGEN     292    292       T->A: Abolishes phosphorylation by PKC.
FT                                {ECO:0000269|PubMed:20188095}.
FT   MUTAGEN     498    498       S->A: Reduces AMPK- and CaMK-dependent
FT                                phosphorylation and the subsequent
FT                                nuclear export. Abolishes nuclear export;
FT                                when associated with A-259.
FT                                {ECO:0000269|PubMed:11081517,
FT                                ECO:0000269|PubMed:18184930}.
FT   MUTAGEN     661    661       S->A: No effect.
FT                                {ECO:0000269|PubMed:11081517}.
FT   MUTAGEN     713    713       S->A: No effect.
FT                                {ECO:0000269|PubMed:11081517}.
FT   MUTAGEN    1086   1086       V->A: Reduces CaMK-dependent nuclear
FT                                export. {ECO:0000269|PubMed:11509672}.
FT   MUTAGEN    1092   1092       L->A: Reduces CaMK-dependent nuclear
FT                                export. {ECO:0000269|PubMed:11509672}.
FT   CONFLICT     37     37       V -> L (in Ref. 6; BX458255).
FT                                {ECO:0000305}.
FT   CONFLICT    139    139       Q -> R (in Ref. 6; BX458255).
FT                                {ECO:0000305}.
FT   CONFLICT    147    147       R -> G (in Ref. 6; BX458255).
FT                                {ECO:0000305}.
FT   CONFLICT    593    593       D -> E (in Ref. 1; AAD29047, 5; AAH51824
FT                                and 7; AAC18040). {ECO:0000305}.
FT   CONFLICT    671    671       S -> N (in Ref. 7; AAC18040).
FT                                {ECO:0000305}.
FT   CONFLICT    684    684       G -> S (in Ref. 7; AAC18040).
FT                                {ECO:0000305}.
FT   CONFLICT   1026   1026       E -> K (in Ref. 7; AAC18040).
FT                                {ECO:0000305}.
FT   CONFLICT   1074   1074       E -> G (in Ref. 7; AAC18040).
FT                                {ECO:0000305}.
FT   CONFLICT   1093   1093       S -> L (in Ref. 7; AAC18040).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1122 AA;  121978 MW;  CF4BE774E3588FEC CRC64;
     MNSPNESDGM SGREPSLEIL PRTSLHSIPV TVEVKPVLPR AMPSSMGGGG GGSPSPVELR
     GALVGSVDPT LREQQLQQEL LALKQQQQLQ KQLLFAEFQK QHDHLTRQHE VQLQKHLKQQ
     QEMLAAKQQQ EMLAAKRQQE LEQQRQREQQ RQEELEKQRL EQQLLILRNK EKSKESAIAS
     TEVKLRLQEF LLSKSKEPTP GGLNHSLPQH PKCWGAHHAS LDQSSPPQSG PPGTPPSYKL
     PLPGPYDSRD DFPLRKTASE PNLKVRSRLK QKVAERRSSP LLRRKDGTVI STFKKRAVEI
     TGAGPGASSV CNSAPGSGPS SPNSSHSTIA ENGFTGSVPN IPTEMLPQHR ALPLDSSPNQ
     FSLYTSPSLP NISLGLQATV TVTNSHLTAS PKLSTQQEAE RQALQSLRQG GTLTGKFMST
     SSIPGCLLGV ALEGDGSPHG HASLLQHVLL LEQARQQSTL IAVPLHGQSP LVTGERVATS
     MRTVGKLPRH RPLSRTQSSP LPQSPQALQQ LVMQQQHQQF LEKQKQQQLQ LGKILTKTGE
     LPRQPTTHPE ETEEELTEQQ EVLLGEGALT MPREGSTESE STQEDLEEED EEDDGEEEED
     CIQVKDEEGE SGAEEGPDLE EPGAGYKKLF SDAQPLQPLQ VYQAPLSLAT VPHQALGRTQ
     SSPAAPGGMK SPPDQPVKHL FTTGVVYDTF MLKHQCMCGN THVHPEHAGR IQSIWSRLQE
     TGLLSKCERI RGRKATLDEI QTVHSEYHTL LYGTSPLNRQ KLDSKKLLGP ISQKMYAVLP
     CGGIGVDSDT VWNEMHSSSA VRMAVGCLLE LAFKVAAGEL KNGFAIIRPP GHHAEESTAM
     GFCFFNSVAI TAKLLQQKLN VGKVLIVDWD IHHGNGTQQA FYNDPSVLYI SLHRYDNGNF
     FPGSGAPEEV GGGPGVGYNV NVAWTGGVDP PIGDVEYLTA FRTVVMPIAH EFSPDVVLVS
     AGFDAVEGHL SPLGGYSVTA RCFGHLTRQL MTLAGGRVVL ALEGGHDLTA ICDASEACVS
     ALLSVELQPL DEAVLQQKPN INAVATLEKV IEIQSKHWSC VQKFAAGLGR SLREAQAGET
     EEAETVSAMA LLSVGAEQAQ AAAAREHSPR PAEEPMEQEP AL
//
